Automatic Bevacizumab Response Prediction in Ovarian Cancer from Digital Pathology Images via Novel AI-based Computational Pipeline

Avatar
Poster
Voice is AI-generated
Connected to paperThis paper is a preprint and has not been certified by peer review

Automatic Bevacizumab Response Prediction in Ovarian Cancer from Digital Pathology Images via Novel AI-based Computational Pipeline

Authors

Alsaiari, A.; Turki, T.; Taguchi, Y.-h.

Abstract

Ovarian cancer is one of the gynecological cancer types, which, if metastasized and not detected early, can cause deaths among women. Therefore, there is a need to accurately predict drug responses to ovarian cancer. A gynecological pathologist inspects abnormality in tissues, followed by providing a report about patients; however, such a diagnostic process is (1) hard; (2) requires experience; and (3) time consuming. Moreover, existing tools are far from perfect. Hence, we present a computational pipeline to improve predicting drug response pertaining to ovarian cancer, derived as follows. First, we download digital pathology images pertaining to ovarian bevacizumab response from the cancer imaging archive repository. We employed histogram of oriented gradients to images, constructing feature vectors, provided to Fisher linear discriminant analysis to change the representation through dimensionality reduction. Then, we provide reduced-dimensionality data for regression analysis through support vector regression coupled with various kernels and calculating the area under the ROC curve (AUC). Experimental results against transformer-based models (ViT and Swin) and other deep learning (DL) models (VGG16, ResNet50, InceptionV3, MobileNetV2, and EfficientNetB6) demonstrate that our approach with radial kernel (named SVRD+R) yielded an AUC performance improvements of 17% against the best-performing transformer-based model (ViT) while obtaining an AUC performance improvements of 14.9% when compared against the best DL-based model (MobileNetV2). These results demonstrate the superiority and feasibility of our AIbased pipeline when tackling prediction problems pertaining to gynecologic cancer studies.

Follow Us on

0 comments

Add comment